EUCALIA

EUCALIA PEG

The PEG Ratio (Price/Earnings-to-Growth) of EUCALIA (286A.T) as of Oct 26, 2026 is 0.28. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.38 — a change of -27.03% (lower).

PEG

0.28

YoY

-27.03%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of EUCALIA is 2025 0.28 . PEG Ratio (Price/Earnings-to-Growth) of EUCALIA was 2024 0.38 . It decreases by -27.03% lower compared to the previous year.

The EUCALIA PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2022
0.78 JPY
Jan 1, 2023
0.73 JPY
Jan 1, 2024
0.38 JPY
Jan 1, 2025
0.28 JPY
The EUCALIA PEG history
YEARPEGYoY
0.28-27.03%
0.38-48.11%
0.73-6.75%
0.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EUCALIA Stock analysis

What does EUCALIA do? EUCALIA Inc generates revenue through three core business segments. The Medical Management Comprehensive Support Business offers management consulting, personnel recruitment, DX support, and fundraising for medical corporations. The Senior Related Business provides nursing care facility operations, admission consultation, and facility introduction services. The Highly Controlled Medical Device Business sells contact lenses and supplies pharmaceutical companies with treatment progress data analysis and sales activity support. Subsidiaries contribute through venture investment, brain checkup services, and real estate transactions. Pharmaceutical companies purchase treatment progress data analysis and sales activity support services. Medical corporations utilize management consulting, recruitment, DX, and fundraising support. Nursing care facility operators and potential residents engage with senior care services. Venture investments and real estate transactions are handled by subsidiaries, supporting the company's broader financial ecosystem. The company's revenue streams are diversified across healthcare support, senior care services, and medical device manufacturing. Medical corporations, pharmaceutical firms, and nursing care facility stakeholders form the primary customer base. Subsidiary activities in venture investment and real estate complement the core business model without direct revenue generation from these segments. EUCALIA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EUCALIA stock

PEG Ratio (Price/Earnings-to-Growth) of EUCALIA is 0.28 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of EUCALIA changed from 0.38 to 0.28, representing a -27.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) EUCALIA since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s EUCALIA with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — EUCALIA

All Key Metrics — EUCALIA